UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
INFORMATION REQUIRED IN PROXY STATEMENT
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of The Securities Exchange
Act of 1934
(Amendment No. __)
Filed by the Registrant ☐
Filed by a Party other than the Registrant ☒
Check the appropriate box:
☒ Preliminary Proxy Statement
☐ Confidential, for Use of the Commission Only (as permitted by
Rule 14a-6(e)(2))
☐ Definitive Proxy Statement
☐ Definitive Additional Materials
☐ Soliciting Material Under Rule 14a-12
GENWORTH FINANCIAL, INC.
(Name of Registrant as Specified in Its Charter)
SCOTT KLARQUIST
(Name of Persons(s) Filing Proxy Statement, if Other Than the
Registrant)
Payment of Filing Fee (Check the appropriate box):
☒ No fee required.
☐ Fee computed on table below per Exchange Act Rules 14a-6(i)(1)
and 0-11.
(1) Title of each class of securities to which transaction applies:
(2) Aggregate number of securities to which transaction applies:
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
(4) Proposed maximum aggregate value of transaction:
(5) Total fee paid:
☐ Fee paid previously with preliminary materials:
☐ Check box if any part of the fee is offset as provided by
Exchange Act Rule 0-11(a)(2) and identify the filing for which the
offsetting fee was paid previously. Identify the previous filing by
registration statement number, or the form or schedule and the date of
its filing.
(1) Amount previously paid:
(2) Form, Schedule or Registration Statement No.:
(3) Filing Party:
(4) Date Filed:
PRELIMINARY COPY SUBJECT TO COMPLETION
DATED APRIL 7, 2022
PROXY STATEMENT OF SCOTT KLARQUIST
_________________________, 2022
Dear Fellow Genworth Financial, Inc. Shareholders:
The undersigned, Scott Klarquist ("Mr Klarquist", "I" or "me"),
currently owns 30,100 shares of Genworth Financial, Inc., a Delaware
corporation ("Genworth", "GNW" or the "Company"). As a shareholder of
Genworth as far back as 2016 and an author of several (in my humble
opinion) prescient analyses of our Company publicly available on the
Internet*, I have sought to engage with the Company's Board of
Directors (the "Board") to improve the corporate governance at the
Company by submitting my nomination as a director candidate for the
2022 Annual Meeting. Unfortunately, the Company declined to nominate me
without having even a single member of Genworth's Nominating and
Corporate Governance Committee contact me (let alone interview me, even
via a simple 15-minute phone call or Zoom meeting).
The Board has determined to re-nominate for election to the Board at
the Company's 2022 annual meeting of shareholders (the "Annual
Meeting") the following members of the Company's Compensation
Committee: Karen E. Dyson, Jill R. Goodman, Melina E. Higgins and
Robert P. Restrepo Jr., (collectively, the "Compensation Committee
Directors"). As further discussed in the attached Proxy Statement, I
believe that Genworth's senior executive compensation system is
seriously flawed and that the continued presence on the Board of the
Compensation Committee Directors has and will continue to harm the
Company's operating performance and stock price.
To take just one obvious data point, consider that Genworth's CEO
James McInerney has been awarded $70 million in total compensation
by our Board since he took office on January 1, 2013 (including $30
million in total cash compensation), while during that period
shareholders have suffered a total loss of 50% on their investment
in GNW stock.
All during a raging bull market, with the S&P 500 up 220% plus
dividends! This largesse to the CEO is all the more insulting to
Genworth shareholders in light of his irrational insistence on backing
no less than 17(!) extensions of the doomed China Oceanwide merger
without any ticking or termination fee
, resulting in the waste of untold millions of shareholder funds and
thousands of Genworth employee man-hours. Clearly something is amiss.
Since I am not proposing an alternate slate of directors, the election
is uncontested despite my opposition to the Compensation Committee
Directors. However, the Company has a director resignation policy in
place for uncontested elections, whereby any nominee in an uncontested
election who does not receive a majority of votes cast shall promptly
tender his or her resignation from the Board of Directors following the
certification of the stockholder vote. Under the policy, the Nominating
and Corporate Governance Committee will assess the appropriateness of
the nominee continuing to serve as a director and will recommend to the
Board of Directors whether to accept or reject the resignation, or
whether other action should be taken. The Board of Directors will act
on the Nominating Committee's recommendation and publicly disclose its
decision and the reason for the decision.
If my proxy solicitation results in any director failing to receive a
majority of the votes cast for his election, then I believe it would
clearly be inappropriate and inconsistent with contemporary corporate
governance for any such director to continue to serve on the Board. I
believe the failure of the Board to accept any such tendered
resignations that may result from the Annual Meeting would be an
egregious violation of proper corporate governance, and in direct
opposition to a clear shareholder directive.
I urge you to carefully consider the information contained in the
accompanying Proxy Statement and support my efforts by signing, dating
and returning the enclosed BLUE proxy card today to
(A) WITHHOLD your vote on the re-election of the
Compensation Committee Directors as directors at the Annual Meeting
[Proposal 1] and (B) vote AGAINST the Company's
advisory vote on executive compensation [Proposal 2]. The accompanying
Proxy Statement and the enclosed BLUE proxy card are
first being mailed to shareholders on or about [_______] [__], 2022.
If you have already voted for the Company's nominees, you have every
right to change your vote by signing, dating and returning a later
dated BLUE proxy card or by voting in person at the
Annual Meeting.
If you have any questions or require any assistance with your vote,
please reach out to me using the contact information listed below.
Thank you for your support,
/s/ Scott Klarquist
Scott Klarquist
* See Seven Corners Capital's articles from 2017 and 2018 on Seeking
Alpha re GNW.
If you have any questions, require assistance in voting your BLUE
proxy card, or need additional copies of my proxy materials, please
contact Mr Klarquist as follows:
[85 Broad Street, 18th Floor]
New York, NY 10005
(646) 592-0498
Email: info@sevencornerscapital.com
PRELIMINARY COPY SUBJECT TO COMPLETION
DATED APRIL 7, 2022
2022 ANNUAL MEETING OF SHAREHOLDERS
OF
GENWORTH FINANCIAL, INC.
_________________________
PROXY STATEMENT
OF
SCOTT KLARQUIST
_________________________
PLEASE SIGN, DATE AND MAIL THE ENCLOSED PROXY CARD TODAY
Scott Klarquist ("Mr Klarquist", "I" or "me") currently owns 30,100
shares of Genworth Financial, Inc., a Delaware corporation ("Genworth",
"GNW" or the "Company"), and seeks your support using the BLUE proxy card at the Company's 2022 annual meeting
of shareholders, scheduled to be held virtually on May 19, 2022, at
9:00 a.m., EST, (including any adjournments, postponements or
continuations thereof and any meeting which may be called in lieu
thereof, the "Annual Meeting"). The BLUE proxy card
will allow shareholders to vote on the following proposals under
consideration at the Annual Meeting:
· Whether to elect nine directors to our Board of Directors (the
"Board"), including the following members of the Company's Compensation
Committee: Karen E. Dyson, Jill R. Goodman, Melina E. Higgins and
Robert P. Restrepo Jr. (collectively, the "Compensation Committee
Directors");
· The advisory vote on the compensation of the Company's named
executive officers;
· The ratification of the appointment of the Company's independent
auditor for the fiscal year ending December 31, 2022; and
· Such other business that is properly brought before the Annual
Meeting.
This Proxy Statement and the enclosed BLUE proxy card
are first being mailed to shareholders on or about [_______] [__],
2022. I am asking you to (A) WITHHOLD
your vote on the re-election of the Compensation Committee Directors as
directors at the Annual Meeting [Proposal 1] and (B) vote AGAINST the Company's advisory vote on the
compensation of the Company's named executive officers [Proposal 2].
Since I am not proposing an alternate slate of directors, the election
is uncontested despite my opposition to the Compensation Committee
Directors. However, the Company has a director resignation policy in
place for uncontested elections, whereby any nominee in an uncontested
election who does not receive a majority of votes cast shall promptly
tender his or her resignation from the Board of Directors following the
certification of the stockholder vote. Under the policy, the Nominating
and Corporate Governance Committee will assess the appropriateness of
the nominee continuing to serve as a director and will recommend to the
Board of Directors whether to accept or reject the resignation, or
whether other action should be taken. The Board of Directors will act
on the Nominating Committee's recommendation and publicly disclose its
decision and the reason for the decision.
1
If this proxy solicitation results in any director failing to receive a
majority of the votes cast for his or her election, then I believe it
would clearly be inappropriate and inconsistent with contemporary
corporate governance for any such director to continue to serve on the
Board. I believe the failure of the Board to accept any such tendered
resignations that may result from the Annual Meeting would be an
egregious violation of proper corporate governance, and in direct
opposition to a clear shareholder directive.
Shareholders are advised that the Company's nine nominees, including
the Compensation Committee Directors, are not my nominees, have not
consented to be named in these proxy materials, and are the nominees of
Genworth. Because the Compensation Committee Directors are not my
nominees and have not consented to be named in this proxy statement,
they are not participants in this solicitation. The names, backgrounds
and qualifications of the Company's nominees, and other information
about them, can be found in the Company's proxy statement. I can
provide no assurance that any of the Company's nominees will serve as
directors if elected or that the Compensation Committee Directors will
submit their resignations if they are elected by a plurality of the
votes cast, but fail to receive a majority.
I intend to vote my shares as follows: WITHHOLD with respect to the
election of the Compensation Committee Directors; FOR all other Company
nominees (other than the Compensation Committee Directors); AGAINST the
approval of the advisory vote on the compensation of the Company's
named executive officers; and FOR the ratification of the Company's
independent auditors for the fiscal year ending December 31, 2022.
Please note, however, that all shares of Common Stock represented by
the enclosed BLUE proxy card will be voted at the Annual Meeting as
marked and, in the absence of specific instructions, will be voted in
accordance with my recommendations and voting instructions specified
herein and in accordance with the discretion of the persons named on
the BLUE proxy card with respect to any other matters that may be voted
upon at the Annual Meeting. Please see the "Voting and Proxy
Procedures" section of this Proxy Statement and the BLUE proxy card for
additional detail.
The Company has set the close of business on March 21, 2022 as the
record date for determining shareholders entitled to notice of and to
vote at the Annual Meeting (the "Record Date"). The mailing address of
the principal executive offices of the Company is 6620 West Broad
Street, Richmond, Virginia 23230. Shareholders of record at the close
of business on the Record Date will be entitled to vote at the Annual
Meeting. As of the Record Date, there were 510,096,390 shares of Common
Stock outstanding.
THIS SOLICITATION IS BEING MADE BY MR KLARQUIST AND NOT ON BEHALF OF
THE BOARD OF DIRECTORS OR MANAGEMENT OF THE COMPANY. I AM NOT AWARE OF
ANY OTHER MATTERS TO BE BROUGHT BEFORE THE ANNUAL MEETING OTHER THAN AS
SET FORTH IN THIS PROXY STATEMENT. SHOULD OTHER MATTERS, WHICH I AM NOT
AWARE OF A REASONABLE TIME BEFORE THIS SOLICITATION, BE BROUGHT BEFORE
THE ANNUAL MEETING, THE PERSONS NAMED AS PROXIES IN THE ENCLOSED BLUE
PROXY CARD WILL VOTE ON SUCH MATTERS IN THEIR DISCRETION.
2
I URGE YOU TO SIGN, DATE AND RETURN THE ENCLOSED PROXY CARD TO (A) WITHHOLD YOUR VOTE ON THE RE-ELECTION OF THE
COMPENSATION COMMITTEE DIRECTORS AS DIRECTORS AT THE ANNUAL MEETING
[PROPOSAL 1] AND (B) VOTE AGAINST THE COMPANY'S
ADVISORY VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE
OFFICERS [PROPOSAL 2].
IF YOU HAVE ALREADY SENT A PROXY CARD FURNISHED BY THE COMPANY, YOU MAY
REVOKE THAT PROXY AND VOTE ON EACH OF THE PROPOSALS DESCRIBED IN THIS
PROXY STATEMENT BY SIGNING, DATING AND RETURNING THE ENCLOSED BLUE PROXY CARD. THE LATEST DATED PROXY IS THE ONLY
ONE THAT COUNTS. ANY PROXY MAY BE REVOKED AT ANY TIME
PRIOR TO THE ANNUAL MEETING BY DELIVERING A WRITTEN NOTICE OF
REVOCATION OR A LATER DATED PROXY FOR THE ANNUAL MEETING OR BY VOTING
AT THE ANNUAL MEETING.
Important Notice Regarding the Availability of Proxy Materials for
the Annual Meeting-This Proxy Statement and my BLUE proxy card are
available at www.sevencornerscapital.com
3
IMPORTANT
Your vote is important, no matter how few shares of Common Stock
you own. I urge you to sign, date, and return the enclosed BLUE
proxy card today to (A) WITHHOLD your vote on the re-election of
the Compensation Committee Directors as directors at the Annual
Meeting [Proposal 1], (B) vote AGAINST the Company's advisory vote
on the compensation of the Company's named executive officers
[Proposal 2], and (C) in accordance with my recommendations on the
other proposal(s) on the agenda for the Annual Meeting.
· If your shares of Common Stock are registered in your own name,
please sign and date the enclosed BLUE proxy card and return it to me
in the enclosed postage-paid envelope today.
· If your shares of Common Stock are held in a brokerage account
or bank, you are considered the beneficial owner of the shares of
Common Stock, and these proxy materials, together with a BLUE voting
form, are being forwarded to you by your broker or bank. As a
beneficial owner, if you wish to vote, you must instruct your broker,
trustee or other representative how to vote. Your broker cannot vote
your shares of Common Stock on your behalf without your instructions.
As a beneficial owner, you may vote the shares at the Annual Meeting
only if you obtain a legal proxy from the broker or bank giving you the
rights to vote the shares.
· Depending upon your broker or custodian, you may be able to vote
either by toll-free telephone or by the Internet. Please refer to the
enclosed voting form for instructions on how to vote electronically.
You may also vote by signing, dating and returning the enclosed voting
form.
Since only your latest dated proxy card will count, I urge you not to
return any proxy card you receive from the Company. Even if you return
the Company proxy card marked "withhold" as a protest against the
incumbent directors, it will revoke any proxy card you may have
previously sent to us. So please make certain that the latest dated
proxy card you return is the BLUE proxy card.
If you have any questions, require assistance in voting your BLUE
proxy card, or need additional copies of my proxy materials, please
contact Mr Klarquist as follows:
[85 Broad Street, 18th Floor]
New York, NY 10005
(646) 592-0498
Email: info@sevencornerscapital.com
4
BACKGROUND TO THE SOLICITATION
The following is a chronology of material events leading up to this
proxy solicitation:
· In late March 2021, Mr Klarquist acquired 100 shares of the
Company's common stock and subsequently transferred these shares into
record ownership.
· On February 2, 2022, Mr. Klarquist delivered a notice of his
intent to nominate himself as a candidate for election to the Board at
the 2022 Annual Meeting (the "Nomination Notice"), stating in the
notice that "while I do not currently intend to solicit proxies for the
2022 annual meeting, I reserve the right to change this decision at a
later date."
· Two days later, on February 4, 2022, Compensation Committee
Director Restrepo purchased 50,000 shares of GNW stock on the open
market, his first such open market purchase of the Company's stock
since joining the Board in 2016.
· On February 11, 2022, the company delivered notice to Mr.
Klarquist that his Nomination Notice did not comply with the
requirements for notices of director nominations contained in the
company's bylaws. The company also provided the company's standard
directors' and officers' questionnaire, as requested by Mr. Klarquist
in his February 2 letter. The next day, on February 12, 2022, Mr
Klarquist responded to the Company's corporate secretary as follows:
"[M]ost (if not all) of the items you claim are "missing" are actually
points about which you are either confused or incorrect. Nevertheless,
while maintaining that there's nothing "missing" in the nomination
letter, I will attempt to re-submit by your deadline in order to make
things more clear for you."
· On February 14, 2022, Mr. Klarquist provided the company with
supplemental information regarding his Nomination Notice.
· On February 15, 2022, the company informed Mr. Klarquist that
his Nomination Notice, as supplemented, continued to not comply with
the requirements for notices of director nominations contained in the
company's bylaws.
· On February 16, 2022, Mr. Klarquist provided the company with
supplemental information regarding his Nomination Notice and a
completed directors' and officers' questionnaire. Mr Klarquist also
made the following request to the Company's corporate secretary:
"Please let me know ASAP when I can speak to any of the so-called
"independent" members of GNW's Governance & Nominating Committee
about my candidacy (since I'm certain they are all in favor of
best-in-class corporate governance, no doubt they will be eager to
interview me given my expertise in identifying companies [like
Genworth] with sub-optimal governance practices). I am available
anytime this week or next to do a Zoom call with them." The Company
never responded to Mr Klarquist's request and offer to meet.
· On March 2, 2022, the company informed Mr. Klarquist that the
Nominating and Corporate Governance Committee had determined not to
recommend his name for election to the Board and that the company
intended to disclose the Nomination Notice in this Proxy Statement.
· On March 11, 2022, Mr. Klarquist informed the company that he
intended to solicit proxies from certain of the company's stockholders.
· On March 14, 2022, Mr. Klarquist submitted a books and records
demand pursuant to Section 220 of the Delaware General Corporation Law,
requesting certain information regarding the record and beneficial
owners of GNW stock in order to communicate with them regarding the
2022 Annual Meeting (the "Books and Records Demand"), and further
notified the company that he had acquired 10,000 shares of the
company's Class A Common Stock.
· On March 18, 2022, Mr. Klarquist informed the company that he
intended to solicit stockholders to vote against the company's director
nominees, rather than in favor of his own candidacy.
· On March 21, 2022, the company responded to the Books and
Records Demand, demanding the payment from Mr Klarquist in advance of
an unspecified amount of money to the Company in order for him to
receive any of the requested books and records.
· On March 23, 2022, Mr. Klarquist informed the company that he
would agree not to solicit any proxies for the 2022 Annual Meeting if
the company agreed to provide him with a subset of the requested books
and records at no cost to him.
· On March 24, 2022, the Company's counsel responded to Mr
Klarquist, again demanding an advance payment (total amount still
unspecified, but approximately $500 for the list of GNW shareholders of
record) for any books and records.
· Later on March 24, 2022, Mr. Klarquist responded to the
company's counsel as follows: "I guess we've reached a deadlock on all
of this & I don't want to waste any more time with fruitless
back-and-forth emails (GNW clearly is not willing to be reasonable), so
I don't see any need to communicate any further on the above points."
· On March 28, 2022, the Company filed its preliminary proxy
statement with respect to the 2022 Annual Meeting.
· On April 5, 2022, the Company filed a revised version of its
preliminary proxy statement with respect to the 2022 Annual Meeting.
Also on April 5, 2022, Mr Klarquist acquired an additional 20,000
shares of the company's Class A Common Stock.
· On April 6, 2022, the Company filed a its definitive
proxy statement with respect to the 2022 Annual Meeting.
Also on April 6, 2022, Mr Klarquist filed an open letter to GNW
shareholders on Form DFAN14A. On April 7, 2022, Mr Klarquist filed his preliminary
proxy statement with respect to the 2022 Annual Meeting.
7
REASONS FOR THE SOLICITATION
Genworth's Compensation Committee Directors Have Failed
Shareholders and Need to be Removed
Incentives determine outcomes. As Charlie Munger has said, "Never,
ever, think about something else when you should be thinking about the
power of incentives." By far the most important incentives for any
corporate executive are the terms of such executive's short and
long-term compensation. Unfortunately, I believe Genworth's senior
executive compensation makes little sense, due to the decisions made by
Genworth's Compensation Committee, as further
explained herein. Therefore I am soliciting shareholders to vote WITHHOLD with respect to the election of each of
Karen E. Dyson, Jill R. Goodman, Melina E. Higgins and Robert P.
Restrepo Jr.
to the Board at the Annual Meeting, because I believe it will send a
strong message to the Board that shareholders are
dissatisfied with Genworth's executive compensation policies and will
cause it to take action to protect the shareholders' investment in our
Company.
Genworth's executive compensation system regarding its senior officers,
such as Genworth's CEO Thomas E. McInerney, appears to be deeply
flawed.
To take just one obvious data point, consider that Genworth's CEO
James McInerney has been awarded $70 million in total compensation
by our Board since he took office on January 1, 2013 through
December 31, 2021 (including $30 million in total cash
compensation), while during that period shareholders have suffered
a total loss of 50% on their investment in Genworth stock
(including receiving zero dividends).
All during a raging bull market, with the S&P 500 up 220% plus
dividends!
CEO McInerney
|
Base Salary
|
Cash Incentive Bonus
|
Stock Awards
|
Option Awards
|
Other Comp
|
TOTAL
|
TOTAL CASH COMP
|
2013
|
973,799
|
3,000,000
|
790,000
|
7,056,600
|
165,665
|
11,986,064
|
3,973,799
|
2014
|
996,803
|
0
|
1,142,250
|
0
|
557,312
|
2,696,365
|
996,803
|
2015
|
1,035,141
|
1,200,000
|
775,000
|
0
|
175,372
|
3,185,513
|
2,235,141
|
2016
|
996,804
|
3,000,000
|
4,215,000
|
0
|
328,453
|
8,540,257
|
3,996,804
|
2017
|
996,804
|
3,000,000
|
4,443,080
|
0
|
525,327
|
8,965,211
|
3,996,804
|
2018
|
996,804
|
2,500,000
|
5,291,240
|
0
|
523,900
|
9,311,944
|
3,496,804
|
2019
|
1,000,000
|
2,500,000
|
5,139,528
|
0
|
463,106
|
9,102,634
|
3,500,000
|
2020
|
1,000,000
|
2,540,000
|
3,350,874
|
0
|
466,714
|
7,357,588
|
3,540,000
|
2021
|
1,000,000
|
3,000,000
|
4,063,966
|
0
|
435,413
|
8,499,379
|
4,000,000
|
Totals
|
8,996,155
|
20,740,000
|
29,210,938
|
7,056,600
|
3,641,262
|
69,644,955
|
29,736,155
|
Source: GNW Proxy Statements 2014-2022. Amounts in $.
This largesse to the CEO is all the more insulting to Genworth
shareholders in light of his irrational insistence on backing
no less than 17(!) extensions of the doomed China Oceanwide merger
without any ticking or termination fee (note that Directors Higgins
and Restrepo were both on our Board throughout the entirety of this
fiasco)
, resulting in the waste of untold millions of shareholder funds and
thousands of Genworth employee man-hours. While CEO McInerney likely
enjoys receiving millions in cash compensation per year courtesy of the
shareholders regardless of whether the shareholders win or lose (what
CEO wouldn't?), he apparently is not willing to bet on himself via our
stock, as he has been dumping GNW shares in recent months at a
staggering pace. Per his SEC Form 4 filings, he sold 150,000 shares on
the open market on February 22nd, as well as an additional
1,005,609 shares on March 1st, in each case at a small
fraction of Genworth's reported book value. Clearly something is amiss.
The Company has a director resignation policy in place for uncontested
elections, whereby any nominee for director in a non-contested election
of directors who receives a greater number of votes "withheld" from his
or her election than votes "for" such election shall submit to the
Board a letter of resignation for consideration by the Nominating and
Corporate Governance Committee. The Nominating and Corporate Governance
Committee (excluding any nominee in question if a member thereof) shall
evaluate such offer of resignation in light of the best interests of
the Company and its shareholders and shall recommend to the Board the
action to be taken with respect thereto. The Board shall then act
promptly with respect to the letter of resignation and the Company
shall publicly disclose the decision of the Board.
8
Genworth's Shareholders Will Be Negatively Impacted by the
Ongoing Tenure of the Compensation Committee Directors
Genworth's executive compensation system is only as good as the
decisions collectively made by the Compensation Committee Directors. In
other words, "garbage in, garbage out." Since almost every public
company (including ours) benchmarks its compensation practices against
those of a self-selected peer group, it is instructive to analyze
Genworth's peer group, which includes the following 14 companies (see
page [47] of Genworth's 2022 proxy statement): Aflac, Inc.; American
Financial Group, Inc.; Assurant, Inc.; CNA Financial Corporation; CNO
Financial Group, Inc.; Fidelity National Financial; First American
Financial Corporation; Hanover Insurance Group; Lincoln National
Corporation; MGIC Investment Corporation; Principal Financial Group,
Inc.; Radian Group; Reinsurance Group of America, Inc.; and Unum Group
(collectively, the "Genworth Peer Group"). Unfortunately, the Genworth
Peer Group bears no resemblance to our company as regards market
capitalization, which is usually (in my experience reviewing proxy
statements) a key determinant in identifying peer groups (in addition
to type of business):
ð Current Genworth market cap: $1.9B, versus current Genworth Peer
Group Average Market Cap: $11.3B (smallest, Radian: $3.8B; largest,
Aflac: $41B)
The average market cap of the Genworth Peer Group is over 5X that
of our company (indeed, the smallest market cap in the Genworth
Peer Group is over double that of Genworth)!
In determining executive compensation, Genworth has no business
comparing itself to competitors with market caps that are 2X to 20X
higher; rather, Genworth should compare itself to similar companies in
the $1 billion to $3 billion market cap range, such as mortgage insurer
NMI Holdings Inc, or "NMIH" (current market cap: $1.7B), whose C-suite
executives make about half of the compensation of Genworth's:
GNW C-suite Top 5
|
Total GNW 2021 Compensation
|
NMIH C-suite Top 5
|
Total NMIH 2021 Compensation
|
McInerney
|
8,499,379
|
Merkle
|
4,970,949
|
Sheehan
|
5,579,800
|
Shuster
|
2,824,871
|
Gupta
|
11,006,561
|
Pollitzer
|
2,822,604
|
Haendiges
|
2,682,654
|
Leatherberry
|
2,436,972
|
Bobitz
|
2,229,729
|
Mathis
|
2,338,198
|
Total
|
29,998,123
|
Total
|
15,393,594
|
Source:
2022 GNW and NMIH Proxy Statements. Amounts in $.
Perhaps unsurprisingly for a company that appears to prioritize its
shareholders by properly reining in corporate expenses, in 2021 the
ratio of the total compensation of NMIH's CEO to its average
employee was a respectable 28:1, whereas the same ratio for
Genworth's CEO was an outrageous 81:1 (no, not a typo), or 3X that
of NMIH.
(See page 78 of Genworth's 2022 Proxy Statement.) Double or triple
(depending on the metric used) the compensation for a vastly inferior
long-term total shareholder return (during the past five years, NMIH's
stock has outperformed Genworth's by approximately 7,000 basis points)
is not something to write home about-and the buck stops with the
enablers of this nonsense, Genworth's Compensation Committee Directors.
Strangely, per page [35] of Genworth's 2022 Proxy Statement, our
Compensation Committee has retained a compensation consultant (Steven
Hall & Partners, LLC) that has just two employees (per its website)
and appears, based on a full-text search on EDGAR, to have represented
just a handful other public companies over the past year, one of which
(Kohl's) is currently embroiled in a proxy war. The challenger in the
Kohl's contest (Macellum Advisors) said this in its March 18, 2022
proxy statement: "We believe that [Kohl's] Board has approved a poorly
designed executive compensation program that insufficiently ties
rewards to performance". Why haven't the Compensation Committee
Directors hired a more reputable firm for compensation advice, such as
Semler Brossy or F.W. Cook? Is it because a tiny firm such as Steven
Hall & Partners, lacking the scale to offset overhead costs enjoyed
by larger compensation consultancies, might just be a bit more
desperate for fee income and therefore more willing to rubber-stamp
whatever compensation scheme our Board comes up with (no matter how
illogical)?
9
The Specifics of Genworth's Executive Compensation System Raise
Troubling Questions
Upon closer examination of the discussion of executive compensation
contained in Genworth's 2022 proxy statement dated April 6, 2022 (the "Company Proxy")
(which runs a mind-boggling 40 pages), a myriad of troubling questions
are raised regarding the specific metrics and criteria used to
determine the compensation for our Company's NEOs, such as the
following:
· The Company Proxy (Page [41]), Note 1, states: "Mr. Bobitz
resigned from his position as Executive Vice President and General
Counsel effective December 31, 2021, but will remain employed with the
company in an advisory role through June 30, 2022." Why is Mr Bobitz
being paid for 6 months after his resignation? What is he "advising"
on, how much is the Company paying him and how many hours per week is
he required to work?
· The Company Proxy (Page [42]), states: "Genworth also reduced
annual operating expenses by approximately $75million on a run-rate
basis." How is this calculated? The line item for consolidated
"acquisition and operating expenses" for both Q4 2021 and full year
2021 was higher year over year, according to the Company's own
financial statements in its 2021 Form 10-K filing.
· The Company Proxy (Page [43]), states: "U.S. Life business
exceeded expectations in its expense management efforts." What are
these expense management targets and where are they disclosed? Also on
Page [43], we are told: "Investments strategic asset production &
environmental, social & governance investment initiatives exceeded
target goals." Similarly, what are these target goals and where are
they disclosed? Lastly on this page we find a sentence beginning with
the following preamble: "In consideration of the favorable feedback
received on our compensation design over the past three years..." Does
the Company really believe that garnering 84%, 90% & 91%
(respectively) over the past 3 years (and, moreover, with these
percentages trending in the wrong direction) on its executive
compensation advisory votes is "favorable"? This is far below what
Genworth's self-defined "peers" seem to receive (see, e.g., AFLAC,
which had results of 96%, 98% and 97% for the same years).
· The Company Proxy (Page [49]) lists multiple "Key Financial
Objectives" for which Genworth's actual 2021 results either almost
reached or barely exceeded the "maximum" level needed for the highest
possible bonus payment. For example, 2021 LTC In-Force Rate Actions
Gross Incremental Premium Approvals came in at $403 million, less than
1% above the $400 million "maximum" bonus threshold for this test.
Similarly, Enact's 2021 Adjusted Operating Income was $520 million, or
99.4% of the $523 million "maximum" bonus threshold for this metric.
And 2021 Net Investment Income was $3,370 million, or 99.8% of the
"maximum" bonus threshold of $3,377 million.
How likely is it that actual 2021 financial results for so many
different uncorrelated financial metrics could so closely mirror
the precise numbers required in order for Genworth's C-suite
executives to cash in "maximum" short-term bonuses?
On what date in 2021 were these "Key Financial Objectives" established
by our Compensation Committee Directors? Were any of these subsequently
amended? Where are Genworth's 2022 key financial objectives disclosed?
If they aren't, why not?
· The Company Proxy (Page [50]), Note 4, refers to "adjusted
levered operating income" and "average ending Genworth's levered equity
attributable to Enact." How is each of these defined/calculated? Where
is the numerical calculation of the "Operating ROE for Enact" metric
for 2021 in the Company Proxy? Why is it determined over trailing 5
quarters, instead of 4? In addition, why did Genworth's 2020 Proxy
Statement refer to "adjusted unlevered operating income" and "unlevered
equity" (i.e., why did it change for 2021)?
-
The Company Proxy (Page [52]) claims that the 2021 short-term
incentive compensation for CEO McInerney was determined "based
on the achievement of the financial and strategic measures
indicated below", yet no such financial or strategic measures,
nor any percentage weightings for such measures for bonus
purposes, are listed below.
(In last year's proxy statement, such measures appeared, but only
34% of the CEO's annual incentive pay that year was tied to
specific financial metrics, while two-thirds was based on undefined
and unmeasured objectives like "Right Size Organization" and "Close
China Oceanwide Transaction OR Implement Strategic Alternatives"
(truly a Pass/Fail test if one ever existed!)) Our Compensation
Committee Directors also lauded him for "developing and executing a
new strategy after the China Oceanwide transaction" and decided to
grant him a bonus for 2021 equal to 150% of his targeted amount
(why 150%?), when he in fact should have been reprimanded (not
rewarded) by the Board for allowing the China Oceanwide debacle to
drag on so long in the first place.
· The Company Proxy on Pages [52-54] discloses that each of the
five Company NEOs achieved between 135% and 150% of their targeted
bonus for 2021, despite Genworth's stock price appreciating a
pedestrian 7% during the year (well below the S&P 500's total
return).
Apparently, at Genworth nobody in the C-suite ever gets a grade of
"B", they all get either "As" or "A-minuses"!
Talk about grade inflation.
· Any discussion of Genworth's long-term incentive compensation
(on Pages [55-60] of the Company Proxy) is moot, given that the Company
should not be handing out any such compensation to its underperforming
executives (especially in light of how much these executives receive in
aggregate short-term pay). However, it is worth noting that the metrics
seem to change with every three-year cycle (likely conveniently for
C-suite insiders), with the 2019-2021 LTI goal consisting solely of
3-year Consolidated Genworth Adjusted Operating Income (itself a
fatally flawed measure, do to its "self-grading" definition [see
below]), which then changed for the 2020-2022 cycle to (A) Enact &
Genworth Mortgage Insurance Australia Adjusted Operating Income (2/3)
and (B) Net Present Value of Approved Rate Actions (1/3), only to
change once again for 2021-2023 to (x) Consolidated Genworth Adjusted
Operating Income (80%) and (y) Total Shareholder Return (20%).
There is no rhyme or reason to these constantly changing metrics,
nor do they appear to result in any increase in Genworth's
long-term share price, which has been stuck around the $4/share
level for the past 5 years.
· Shareholders should note that the definition of "Genworth
Consolidated Adjusted Operating Income" on Page [57] of the Company
Proxy specifically excludes a laundry list of items for compensation
purposes (virtually all of which might negatively affect the
measurement of such income, rendering the metric practically useless in
gauging true operating performance). These exclusions include "impacts
from in-force reserve changes from future period assumption changes
(e.g. mortality, interest rate, expense, lapse, morbidity), methodology
changes (e.g. changes that would arise from a system conversion),
changes in foreign exchange rates, tax changes based on updated
regulations, guidance, assessments, or refinements related to technical
areas of the Tax Cuts and Jobs Act, legal fees and settlement costs
related to merger & acquisition litigation, any strategic
deal-related expenses (e.g. 3rd party legal, actuarial or reinsurance
support for negotiating or implementing a transaction), and
professional fees related to the implementation of the Long Duration
Targeted Improvements ("LDTI") accounting standard".
The Company even excludes the effect of "strategic transactions in
2021, 2022 or 2023 that are not included in forecast assumptions"
in determining its 3-year LTI operating performance.
· In demonstrating the
Compensation Committee Directors' uncanny ability to needlessly
squander shareholder funds
, the Company Proxy on Pages [65-66] discloses that Genworth (meaning
us, the shareholders) not only paid a so-called "Cash Retention Bonus"
of $3,000,000 to Enact's CEO Gupta in 2021 (aren't his Base Salary plus
various cash and stock bonuses retention payments enough?), but it also
paid a so-called "Cash Separation Payment" of $1,875,000 to Genworth's
former COO Schneider, who quit in January 2021 (in return for quitting,
Mr Schneider also received a pro-rated annual incentive payment of
$468,750, payments related to health benefits of $51,374 and
accelerated RSU vesting with an aggregate value of $753,719).
10
Are the Compensation Committee Directors Just Here for the
Networking and Easy Money?
In light of the foregoing, rational Genworth shareholders should ask
themselves: Who are the Compensation Committee Directors serving on
behalf of, the shareholders (the true owners of the Company) or the
members of Genworth's C-suite? We might conceivably take solace that
the answer is the former if any of the Compensation Committee Directors
had demonstrated a firm commitment to align their financial interests
with those of the shareholders in the past, but in my view this sadly
has not been the case.
None of Compensation Committee Directors Higgins, Dyson or Goodman
has ever purchased a single share of Genworth stock on the open
market, and, while Director Restrepo deserves some credit in
recently buying 50,000 shares, his purchase came two days after I
submitted my director nomination and a proxy contest was suddenly
in prospect. A coincidence? Or was Director Restrepo's purchase
defensive and reactionary?
Prior to the submission of my director nomination, Mr Restrepo had
never bothered to purchase open market shares of Genworth stock since
joining our Board in late 2016.
In addition, each of the Compensation Committee Directors serves on the
boards of various other public and non-public companies, calling into
question their willingness to challenge entrenched management.
Compensation Committee Director Restrepo, for example, also serves on
the boards of RLI Corp (where he made $175,000 in director fees for
2021) and Enact Holdings (thereby earning double director fees courtesy of Genworth
shareholders, since we own 82% of Enact!). Compensation Committee
Director Dyson (the committee chair), on the other hand, serves on the
boards of USAA Federal Savings Bank (since October 2017); CALIBRE
Systems, Inc. (since October 2018); and the Army Emergency Relief
Organization (since 2020). Why rock the boat as a director, if one can
instead rubber-stamp the CEO's lucrative compensation package and
empire-building plans and thereby collect director fees well into the
six figures, while working just a few weeks a year?
Each of Genworth's Compensation Committee Directors, for example,
stands to make a *minimum* of $270,000 in director fees for serving
on our Board (versus $242,000 in 2020), plus additional fees for
serving as a committee chair or board chair-that is, so long as
they don't get ejected from the director suite for being
obstreperous
(the Nomination Committee can simply decline to renominate any such
director at the next annual meeting, perhaps following a not-so-subtle
hint from the CEO).
Lastly, in a strange side note, one of the Compensation Committee
Directors has her age listed incorrectly in Genworth's preliminary
proxy statement. It seems Director Dyson should currently be either 63
or 64 years old (rather than 62), based on her college graduation date
of 1980 (per an article about her on Missouri State's website). One
wonders, what other professional credentials listed in Genworth's
preliminary proxy statement for our Directors will prove to be
inaccurate upon closer examination?
11
PROPOSAL NO. 1
ELECTION OF DIRECTORS
The Board currently has nine members up for election at the Annual
Meeting, including the Compensation Committee Directors. I am seeking
your support to WITHHOLD your vote on the re-election
of the Compensation Committee Directors as directors
at the Annual Meeting. The names, backgrounds and qualifications of the
Company's nominees, and other information about them, can be found in
the Company's proxy statement.
Since I am not proposing an alternate slate of directors, the election
is considered to be uncontested despite my opposition to the
Compensation Committee Directors. However, the Company has a director
resignation policy in place for uncontested elections, whereby any
director who receives a greater number of votes "withheld" from his or
her election than votes "for" such election must submit to the Board a
letter of resignation for consideration by the Nominating and Corporate
Governance Committee. Under the policy, the Nominating and Corporate
Governance Committee (excluding any nominee in question if a member
thereof) will then evaluate such offer of resignation in light of the
best interests of the Company and its shareholders and recommend to the
Board the action to be taken with respect thereto. Promptly following
receipt of the recommendation of the Nominating and Corporate
Governance Committee, the Board (excluding any nominee in question)
would act with respect to such letter of resignation and shall notify
the nominee of its decision.
If I am successful in soliciting your support to WITHHOLD your vote
from the election of the Compensation Committee Directors such that
each of the Compensation Committee Directors receive more votes
"withheld" from his election than votes "for" his election at the
Annual Meeting, each of the Compensation Committee Directors must
tender his resignation to the Board for consideration by the Nominating
and Corporate Governance Committee. I believe the failure of the Board
to insist on the resignations of the Compensation Committee Directors
in the event they fail to receive a majority of the votes cast for
their election would be in direct opposition to a clear shareholder
directive and inconsistent with the Company's Governance Guidelines.
Shareholders are advised that the Company's nine nominees, including
the Compensation Committee Directors, are not the nominees of Mr
Klarquist, have not consented to be named in these proxy materials, and
are the nominees of Genworth. Because the Compensation Committee
Directors are not my nominees and have not consented to be named in
this proxy statement, they are not participants in this solicitation.
The names, backgrounds and qualifications of the Company's nominees,
and other information about them, can be found in the Company's proxy
statement. This Proxy Statement does not include authority to vote for
the Compensation Committee Directors. Should you choose to vote in
favor of either of the Compensation Committee Directors you must use
the Company's proxy card. I can provide no assurance that any of the
Company's nominees will serve as directors if elected or that the
Compensation Committee Directors will submit their resignations if they
are elected by a plurality of the votes cast, but fail to receive a
majority.
I STRONGLY URGE YOU TO "WITHHOLD" YOUR VOTE FROM THE ELECTION OF
KAREN E. DYSON, JILL R. GOODMAN, MELINA E. HIGGINS AND ROBERT P.
RESTREPO JR.
ON THE ENCLOSED BLUE PROXY CARD.
I MAKE NO RECOMMENDATION WITH RESPECT TO THE ELECTION OF THE OTHER
COMPANY NOMINEES AND INTEND TO VOTE MY SHARES "FOR" THEIR ELECTION.
12
PROPOSAL NO. 2
ADVISORY VOTE TO APPROVE THE COMPENSATION OF THE COMPANY'S NAMED
EXECUTIVE OFFICERS
As discussed in further detail in the Company's proxy statement and
pursuant to Section 14A of the Securities Exchange Act of 1934, as
amended, the Company is asking shareholders to approve, on an advisory
basis, the Company's compensation of its named executive officers.
Accordingly, the Company is asking shareholders to vote FOR the
approval, on an advisory basis, of the compensation of the Company's
named executive officers.
This vote is an advisory vote only and will not be binding on the
Company, the Board of Directors or the Compensation Committee, and will
not be construed as overruling a decision by, or creating or implying
any additional fiduciary duty for, the Board of Directors or the
Compensation Committee. The Compensation Committee will consider the
outcome of the vote when making future compensation decisions for the
Named Executive Officers.
I have serious concerns with the compensation to the Company's named
executive officers and therefore believe shareholders should vote AGAINST this proposal. [SEE DISCUSSION BEGINNING ON
PAGE 8 ABOVE].
I RECOMMEND A VOTE "AGAINST" THE APPROVAL OF THE ADVISORY
RESOLUTION APPROVING THE COMPENSATION OF THE COMPANY'S NAMED
EXECUTIVE OFFICERS AND INTEND TO VOTE MY SHARES "AGAINST" THIS
PROPOSAL.
13
PROPOSAL NO. 3
RATIFICATION OF APPOINTMENT OF
THE INDEPENDENT AUDITOR
As discussed in further detail in the Company's proxy statement, the
Audit Committee of the Board (the "Audit Committee") has selected KPMG
LLP ("KPMG") to act as the Company's independent auditor for the fiscal
year ending December 31, 2022.
According to the Company, none of the Company's certificate of
incorporation, Bylaws or anything else require that the Company's
shareholders approve the appointment of KPMG as the Company's
independent auditor. The Company has stated that the Audit Committee
will consider the results of the shareholder vote for this proposal
and, in the event of a negative vote, will reconsider its selection of
KPMG. Even if the appointment is ratified, the Audit Committee, in its
discretion, may change the appointment at any time during the year if
it determines that a change would be in the best interests of the
Company and its shareholders.
The favorable vote of the holders of a majority of the shares of Common
Stock represented in person or by proxy and entitled to vote on the
proposal at the Annual Meeting is required to ratify the selection of
KPMG.
I MAKE NO RECOMMENDATION WITH RESPECT TO THE RATIFICATION OF THE
SELECTION OF KPMG AS THE COMPANY'S INDEPENDENT AUDITOR FOR THE
FISCAL YEAR ENDING DECEMBER 31, 2022, AND INTEND TO VOTE MY SHARES
"FOR" THIS PROPOSAL.
14
VOTING AND PROXY PROCEDURES
Shareholders are entitled to one vote for each share of Genworth's
Class A Common Stock (the "Common Stock") held of record on the Record
Date with respect to each matter to be acted on at the Annual Meeting.
Only shareholders of record on the Record Date will be entitled to
notice of and to vote at the Annual Meeting. Shareholders who sell
their shares of Common Stock before the Record Date (or acquire them
without voting rights after the Record Date) may not vote such shares.
Shareholders of record on the Record Date will retain their voting
rights in connection with the Annual Meeting even if they sell such
shares after the Record Date. Based on publicly available information,
Mr Klarquist believes that the only outstanding class of securities of
the Company entitled to vote at the Annual Meeting is the shares of
Common Stock.
Shares of Common Stock represented by properly executed BLUE proxy
cards will be voted at the Annual Meeting as marked and, in the absence
of specific instructions, will be voted WITHHOLD with
respect to the election of the Compensation Committee Directors, FOR all other Company nominees (other than the
Compensation Committee Directors), AGAINST the
advisory resolution approving the compensation of the named executive
officers, and FOR the ratification of the appointment
of KPMG LLP as the independent auditor of the Company for the fiscal
year ending December 31, 2022.
Shareholders are advised that the Company's nine nominees, including
the Compensation Committee Directors, are not the nominees of Mr
Klarquist, have not consented to be named in these proxy materials, and
are the nominees of Genworth. Because the Compensation Committee
Directors are not my nominees and have not consented to be named in
this proxy statement, they are not participants in this solicitation.
The names, backgrounds and qualifications of the Company's nominees,
and other information about them, can be found in the Company's proxy
statement. This Proxy Statement does not include authority to vote for
the Compensation Committee Directors. Should you choose to vote in
favor of either of the Compensation Committee Directors you must use
the Company's proxy card. I can provide no assurance that any of the
Company's nominees will serve as directors if elected or that the
Compensation Committee Directors will submit their resignations if they
are elected by a plurality of the votes cast, but fail to receive a
majority.
QUORUM; BROKER NON-VOTES; DISCRETIONARY VOTING
A quorum is the minimum number of shares of Common Stock that must be
represented at a duly called meeting in person or by proxy in order to
legally conduct business at the meeting. The presence, in person or by
proxy, of the holders of at least a majority of the shares entitled to
vote at the Annual Meeting will be considered a quorum for the
transaction of business.
Abstentions are counted as present and entitled to vote for purposes of
determining a quorum. If you vote to abstain on one or more proposals,
your shares of Common Stock will be counted as present for purposes of
determining a quorum unless you vote to abstain on all proposals.
According to the Company's proxy statement, abstentions and broker
non-votes (if any) are counted as present for purposes of establishing
a quorum at the Annual Meeting. However, if you hold your shares in
street name and do not provide voting instructions to your broker, your
shares will not be voted on any proposal on which your broker does not
have discretionary authority to vote (a "broker non-vote"). Under
applicable rules, your broker will not have discretionary authority to
vote your shares at the Annual Meeting on any of the proposals.
If you are a shareholder of record, you must deliver your vote by mail,
attend the Annual Meeting in person and vote, vote by Internet or vote
by telephone to be counted in the determination of a quorum.
15
VOTES REQUIRED FOR APPROVAL
Election of Directors
─ The Company has adopted a plurality vote standard for director
elections. However, under the Company's director resignation
policy set forth in its Governance Guidelines, any nominee for director
in a non-contested election of directors who receives a greater number
of votes "withheld" from his or her election than votes "for" such
election must submit to the Board a letter of resignation for
consideration by the Nominating and Corporate Governance Committee. The
Nominating and Corporate Governance Committee (excluding any nominee in
question if a member thereof) will evaluate such offer of resignation
in light of the best interests of the Company and its shareholders and
will recommend to the Board the action to be taken with respect
thereto. The Board will then act promptly with respect to the letter of
resignation and the Company will publicly disclose the decision of the
Board.
Since I am not proposing an alternate slate of directors, the election
is considered to be uncontested despite my opposition to the
Compensation Committee Directors.
Advisory Vote on Executive Compensation
─ According to the Company's proxy statement, the affirmative
vote of a majority of the shares of Common Stock, represented
in person or by proxy at the Annual Meeting and entitled to vote on the
matter, is required to approve of the Company's executive compensation.
The Company's proxy statement notes, however, that this vote is
advisory only and will not be binding. The results of the vote on this
proposal will be taken into consideration by the Company, the Board or
the appropriate committee of the Board, as applicable, when making
future decisions regarding these matters.
Ratification of the Selection of Accounting Firm
─ According to the Company's proxy statement, the affirmative
vote of a majority of the shares of Common Stock, represented
in person or by proxy at the Annual Meeting and entitled to vote on the
matter, is required to ratify the selection of KPMG. The Company's
proxy statement notes, however, that this vote is advisory only and
will not be binding. The results of the vote on this proposal will be
taken into consideration by the Company, the Board or the appropriate
committee of the Board, as applicable, when making future decisions
regarding these matters.
If you sign and submit your BLUE proxy card without specifying how you
would like your shares voted, your shares will be voted in accordance
with my recommendations specified herein and in accordance with the
discretion of the persons named on the BLUE proxy card with respect to
any other matters that may be voted upon at the Annual Meeting.
REVOCATION OF PROXIES
Shareholders of the Company may revoke their proxies at any time prior
to exercise by attending the Annual Meeting and voting (although
attendance at the Annual Meeting will not in and of itself constitute
revocation of a proxy) or by delivering a written notice of revocation.
The delivery of a subsequently dated proxy which is properly completed
will constitute a revocation of any earlier proxy. The revocation may
be delivered either to me at the address set forth on the back cover of
this Proxy Statement or to the Company at 6620 West Broad Street,
Richmond, Virginia 23230 or any other address provided by the Company.
Although a revocation is effective if delivered to the Company, I
request that either the original or photostatic copies of all
revocations be mailed to Mr Klarquist at the address set forth on the
back cover of this Proxy Statement so that I will be aware of all
revocations and can more accurately determine if and when proxies have
been received from the holders of record on the Record Date of a
majority of the shares entitled to be voted at the Annual Meeting.
Additionally, I may use this information to contact shareholders who
have revoked their proxies to solicit later dated proxies for a vote to
withhold on the Compensation Committee Directors.
IF YOU WISH TO VOTE WITHHOLD ON THE ELECTION OF THE COMPENSATION
COMMITTEE DIRECTORS TO THE BOARD, PLEASE SIGN, DATE AND RETURN
PROMPTLY THE ENCLOSED BLUE PROXY CARD IN THE POSTAGE-PAID
ENVELOPE PROVIDED.
16
SOLICITATION OF PROXIES
The solicitation of proxies pursuant to this Proxy Statement is being
made by Mr Klarquist. Proxies may be solicited by mail, facsimile,
telephone, electronic mail, in person and by advertisements.
The entire expense of soliciting proxies is being borne by Mr
Klarquist. Costs of this solicitation of proxies are currently
estimated to be approximately (A) in cash, up to $12,000 (including,
but not limited to, costs incidental to the solicitation) and (B) in
kind, up to [$150,000 in value of legal & other solicitation
services being performed by Mr Klarquist in his individual capacity, as
opposed to being performed by third-party service providers such as law
firms and proxy solicitors (as is typical in proxy contests)]. Mr
Klarquist estimates that through the date hereof his expenses in
furtherance of, or in connection with, (i) in cash, negligible and (ii)
in kind, [$__,000]. To the extent legally permissible, if I am
successful in its proxy solicitation, I intend to seek reimbursement
from the Company for the expenses I incur in connection with this
solicitation. I do not intend to submit the question of such
reimbursement to a vote of security holders of the Company.
ADDITIONAL PARTICIPANT INFORMATION
[Not applicable]
17
Mr Klarquist beneficially owns 30,100 shares of GNW Class A common
stock (100 shares of record and 30,000 beneficially but not of record).
He disclaims beneficial ownership of shares of Common Stock that he
does not directly own. The shares of Common Stock purchased by Mr
Klarquist were purchased with working capital. Positions in the shares
of Common Stock held in margin accounts may be pledged as collateral
security for the repayment of debit balances in such accounts. Since
other securities are held in such margin accounts in addition to the
Common Stock, it may not possible to determine the amounts, if any, of
margin used to purchase the shares of Common Stock held by Mr Klarquist
any one time.
Except as set forth in this Proxy Statement, (i) during the past ten
(10) years, no Participant has been convicted in a criminal proceeding
(excluding traffic violations or similar misdemeanors); (ii) no
Participant directly or indirectly beneficially owns any securities of
the Company; (iii) no Participant owns any securities of the Company
which are owned of record but not beneficially; (iv) no Participant has
purchased or sold any securities of the Company during the past two
years; (v) no part of the purchase price or market value of the
securities of the Company owned by any Participant is represented by
funds borrowed or otherwise obtained for the purpose of acquiring or
holding such securities; (vi) no Participant is, or within the past
year was, a party to any contract, arrangements or understandings with
any person with respect to any securities of the Company, including,
but not limited to, joint ventures, loan or option arrangements, puts
or calls, guarantees against loss or guarantees of profit, division of
losses or profits, or the giving or withholding of proxies; (vii) no
associate of any Participant owns beneficially, directly or indirectly,
any securities of the Company; (viii) no Participant owns beneficially,
directly or indirectly, any securities of any parent or subsidiary of
the Company; (ix) no Participant or any of his, her or its associates
was a party to any transaction, or series of similar transactions,
since the beginning of the Company's last fiscal year, or is a party to
any currently proposed transaction, or series of similar transactions,
to which the Company or any of its subsidiaries was or is to be a
party, in which the amount involved exceeds $120,000; (x) no
Participant or any of his, her or its associates has any arrangement or
understanding with any person with respect to any future employment by
the Company or its affiliates, or with respect to any future
transactions to which the Company or any of its affiliates will or may
be a party; (xi) no Participant has a substantial interest, direct or
indirect, by securities holdings or otherwise, in any matter to be
acted on at the Annual Meeting; (xii) no Participant holds any
positions or offices with the Company; (xiii) no Participant has a
family relationship with any director, executive officer, or person
nominated or chosen by the Company to become a director or executive
officer; and (xiv) no companies or organizations, with which any of the
Participants has been employed in the past five years, is a parent,
subsidiary or other affiliate of the Company. There are no material
proceedings to which any Participant or any of his, her or its
associates is a party adverse to the Company or any of its subsidiaries
or has a material interest adverse to the Company or any of its
subsidiaries.
18
OTHER MATTERS AND ADDITIONAL INFORMATION
I am unaware of any other matters to be considered at the Annual
Meeting. However, should other matters, which I am not aware of at a
reasonable time before this solicitation, be brought before the Annual
Meeting, the persons named as proxies on the enclosed BLUE proxy card will vote on such matters in their
discretion.
Some banks, brokers and other nominee record holders may be
participating in the practice of "householding" proxy statements and
annual reports. This means that only one copy of this Proxy Statement
may have been sent to multiple shareholders in your household. I will
promptly deliver a separate copy of the document to you if you write to
me using the contact information on the back cover of this proxy
statement. If you want to receive separate copies of my proxy materials
in the future, or if you are receiving multiple copies and would like
to receive only one copy for your household, you should contact your
bank, broker or other nominee record holder, or you may contact me at
the above address and phone number.
The information concerning the Company and the proposals in the
Company's proxy statement contained in this Proxy Statement has been
taken from, or is based upon, publicly available documents on file with
the SEC and other publicly available information. Although I have no
knowledge that would indicate that statements relating to the Company
contained in this Proxy Statement, in reliance upon publicly available
information, are inaccurate or incomplete, to date I have not had
access to the books and records of the Company, was not involved in the
preparation of such information and statements and am not able to
verify such information and statements. All information relating to any
person other than the Participants is given only to my knowledge.
You should not assume that the information contained in this Proxy
Statement is accurate as of any date other than the date of this proxy
statement, and the mailing of this Proxy Statement to shareholders
shall not create any implication to the contrary.
SHAREHOLDER PROPOSALS
According to the Company's proxy statement, for a shareholder proposal
to be considered for inclusion in the Company's proxy statement for the
annual meeting next year, the written proposal must be received by the
Corporate Secretary of the Company at their principal executive offices
no later than [December __, 2022]. If the date of next year's annual
meeting is moved more than 30 days before or after the anniversary date
of the Annual Meeting, the deadline for inclusion of proposals in the
Company's proxy statement is instead a reasonable time before the
Company begins to print and mail its proxy materials.
According to the Company's proxy statement, for a shareholder proposal
that is not intended to be included in the Company's proxy statement
under Rule 14a-8 or for a shareholder to nominate a director for
election to the Board for the annual meeting next year, the shareholder
must give timely notice to the Corporate Secretary of the Company in
accordance with the Company's Bylaws, which, in general, require that
the notice be received by the Corporate Secretary of the Company:
-
Not earlier than [January 19, 2023], and
-
Not later than the close of business on [February 18, 2023].
19
According to the Company's proxy statement, if the date of next year's
annual meeting is moved more than 30 days before or after the
anniversary date of the Annual Meeting, then notice of a shareholder
proposal that is not intended to be included in the Company's proxy
statement under Rule 14a-8 or notice of a director nomination must be
received no later than the close of business on the tenth day following
the day on which notice of the date of such annual meeting is mailed to
the shareholders or the date on which public disclosure of the date of
such annual meeting is made, whichever is first.
CERTAIN ADDITIONAL INFORMATION
I HAVE OMITTED FROM THIS PROXY STATEMENT CERTAIN DISCLOSURE REQUIRED BY
APPLICABLE LAW THAT IS EXPECTED TO BE INCLUDED IN THE COMPANY'S PROXY
STATEMENT RELATING TO THE UPCOMING ANNUAL MEETING BASED ON MY RELIANCE
ON RULE 14A-5(C) UNDER THE EXCHANGE ACT. THIS DISCLOSURE IS EXPECTED TO
INCLUDE, AMONG OTHER THINGS, CURRENT BIOGRAPHICAL INFORMATION ON THE
COMPANY'S DIRECTORS AND EXECUTIVE OFFICERS, INFORMATION CONCERNING
EXECUTIVE AND DIRECTOR COMPENSATION, INFORMATION CONCERNING THE
COMMITTEES OF THE BOARD AND OTHER INFORMATION CONCERNING THE BOARD,
INFORMATION CONCERNING CERTAIN RELATIONSHIPS AND RELATED PARTY
TRANSACTIONS, INFORMATION ABOUT THE COMPANY'S INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM AND OTHER IMPORTANT INFORMATION. SEE SCHEDULE I
FOR INFORMATION REGARDING PERSONS WHO BENEFICIALLY OWN MORE THAN 5% OF
THE SHARES AND THE OWNERSHIP OF THE SHARES BY THE DIRECTORS AND
MANAGEMENT OF THE COMPANY.
The information concerning the Company contained in this Proxy
Statement and the Schedule attached hereto has been taken from, or is
based upon, publicly available information.
________________
Your vote is important. No matter how many or how few shares you
own, please vote WITHHOLD with respect to the election of the
Compensation Committee Directors by marking, signing, dating and
mailing the enclosed BLUE proxy card promptly.
Thank you,
Scott Klarquist
April [__], 2022
20
SCHEDULE I
Below is information regarding persons who beneficially own more than
5% of the Common Shares and the ownership of Common Shares by the
Company's directors and officers.
|
|
Beneficial Ownership
|
|
|
Name of Beneficial Owner
|
|
Number of
Shares
|
|
Percentage
|
|
Other Non-Management
Director Stock-Based Holdings(1)
|
BlackRock, Inc.(2)
|
|
72,937,368
|
|
14.4%
|
|
|
The Vanguard Group, Inc.(3)
|
|
55,360,357
|
|
10.9%
|
|
|
Thomas J. McInerney
|
|
4,039,625
|
|
*
|
|
|
Daniel J. Sheehan IV(4)
|
|
1,522,651
|
|
*
|
|
|
Rohit Gupta(4)
|
|
443,166
|
|
*
|
|
|
Brian Haendiges(4)
|
|
63,450
|
|
*
|
|
|
Ward E. Bobitz(4)
|
|
496,563
|
|
*
|
|
|
Kevin D. Schneider(5)
|
|
268,097
|
|
*
|
|
|
G. Kent Conrad
|
|
-
|
|
-
|
|
222,832
|
Karen E. Dyson
|
|
-
|
|
-
|
|
31,961
|
Jill R. Goodman
|
|
-
|
|
-
|
|
29,311
|
Melina E. Higgins
|
|
-
|
|
-
|
|
236,913
|
Howard D. Mills
|
|
-
|
|
-
|
|
29,311
|
Debra J. Perry
|
|
-
|
|
-
|
|
151,403
|
Robert P. Restrepo Jr.
|
|
50,000
|
|
*
|
|
151,403
|
Elaine A. Sarsynski(6)
|
|
-
|
|
-
|
|
-
|
Ramsey D. Smith
|
|
-
|
|
-
|
|
29,311
|
All directors and executive officers as a group (15
persons)(7)
|
|
6,208,293
|
|
1.2%
|
|
|
|
|
*
|
Less than 1%.
|
|
|
|
|
|
|
|
|
I-1
IMPORTANT
Tell the Board what you think! Your vote is important. No matter how
many shares of Common Stock you own, please give Mr Klarquist your
proxy to vote WITHHOLD with respect to the election of the Compensation Committee Directors and in accordance
with Mr Klarquist's recommendations on the other proposal(s) on the
agenda for the Annual Meeting by taking three steps:
· SIGNING the enclosed BLUE proxy card;
· DATING the enclosed BLUE proxy card; and
· MAILING the enclosed BLUE proxy card TODAY in the envelope
provided (no postage is required if mailed in the United States).
If any of your shares of Common Stock are held in the name of a
brokerage firm, bank, bank nominee or other institution, only it
can vote such shares of Common Stock and only upon receipt of your
specific instructions.
Depending upon your broker or custodian, you may be able to vote either by toll-free telephone or by the Internet.
Please refer to the enclosed voting form for instructions on how to
vote electronically. You may also vote by signing, dating and returning
the enclosed BLUE voting form.
If you have any questions or require any additional information
concerning this Proxy Statement, please contact Mr Klarquist at the
address set forth
below.
If you have any questions, require assistance in voting your BLUE
proxy card, or need additional copies of my proxy materials, please
contact Mr Klarquist as follows:
[85 Broad Street, 18th Floor]
New York, NY 10005
(646) 592-0498
Email: info@sevencornerscapital.com
PRELIMINARY COPY SUBJECT TO COMPLETION
DATED APRIL 5, 2022
GENWORTH FINANCIAL, INC.
2022 ANNUAL MEETING OF SHAREHOLDERS
THIS PROXY IS SOLICITED ON BEHALF OF SCOTT KLARQUIST IN HIS PROXY
SOLICITATION
THE BOARD OF DIRECTORS OF GENWORTH FINANCIAL, INC.
IS NOT SOLICITING THIS PROXY
P R O X
Y
The undersigned appoints Scott Klarquist as agent and attorney with
full power of substitution to vote all shares of common stock of
Genworth Financial, Inc. (the "Company") which the undersigned would be
entitled to vote, if present, at the 2022 annual meeting of
shareholders of the Company scheduled to be held virtually on May 19,
2022, at 9:00 a.m., EST (including any adjournments or postponements
thereof and any meeting called in lieu thereof, the "Annual Meeting").
The undersigned hereby revokes any other proxy or proxies heretofore
given to vote or act with respect to the shares of common stock of the
Company held by the undersigned, and hereby ratifies and confirms all
action the herein named attorneys and proxies, their substitutes, or
any of them may lawfully take by virtue hereof. If properly executed,
this Proxy will be voted as directed on the reverse and in the
discretion of the herein named attorneys and proxies or their
substitutes with respect to any other matters as may properly come
before the Annual Meeting that are unknown to Scott Klarquist a
reasonable time before this solicitation.
SHAREHOLDERS ARE ADVISED THAT THE COMPANY'S NOMINEES, INCLUDING
KAREN E. DYSON, JILL R. GOODMAN, MELINA E. HIGGINS AND ROBERT P.
RESTREPO JR., ARE NOT THE NOMINEES OF MR KLARQUIST, HAVE NOT
CONSENTED TO BE NAMED IN THESE PROXY MATERIALS, AND ARE THE
NOMINEES OF GENWORTH. BECAUSE THE COMPENSATION COMMITTEE DIRECTORS
ARE NOT MY NOMINEES AND HAVE NOT CONSENTED TO BE NAMED IN THIS
PROXY STATEMENT, THEY ARE NOT PARTICIPANTS IN THIS SOLICITATION.
THIS PROXY WILL BE VOTED AS DIRECTED. IF NO DIRECTION IS INDICATED
WITH RESPECT TO THE PROPOSALS ON THE REVERSE, THIS PROXY WILL BE
VOTED "WITHHOLD" ON THE ELECTION OF KAREN E. DYSON, JILL R.
GOODMAN, MELINA E. HIGGINS AND ROBERT P. RESTREPO JR., "FOR" ALL
OTHER COMPANY NOMINEES, "AGAINST" PROPOSAL NO. 2 AND "FOR" PROPOSAL
NO. 3.
This Proxy will be valid until the completion of the Annual Meeting.
This Proxy will only be valid in connection with Mr Klarquist's
solicitation of proxies for the Annual Meeting.
IMPORTANT: PLEASE SIGN, DATE AND MAIL THIS BLUE PROXY CARD
PROMPTLY!
CONTINUED AND TO BE SIGNED ON REVERSE SIDE
BLUE
PROXY CARD
[X] Please mark vote as in this example
MR KLARQUIST STRONGLY RECOMMENDS THAT SHAREHOLDERS VOTE "WITHHOLD" ON
THE ELECTION OF KAREN E. DYSON, JILL R. GOODMAN, MELINA E. HIGGINS AND
ROBERT P. RESTREPO JR., MAKES NO RECOMMENDATION WITH RESPECT TO THE
ELECTION OF THE OTHER COMPANY NOMINEES, RECOMMENDS THAT SHAREHOLDERS
VOTE AGAINST PROPOSAL NO. 2 AND MAKES NO RECOMMENDATION WITH RESPECT TO
PROPOSAL 3.
1. Election of Directors.
WITHHOLD ON KAREN E. DYSON, JILL R. GOODMAN,
|
WITHHOLD ON ALL
|
WITHHOLD ON KAREN E. DYSON, JILL R. GOODMAN,
|
|
MELINA E. HIGGINS AND
|
COMPANY
|
MELINA E. HIGGINS AND
|
|
ROBERT P. RESTREPO JR.
|
NOMINEES
|
ROBERT P. RESTREPO JR.
|
AND FOR THE OTHER
|
|
(EXCEPT AS WRITTEN BELOW); AND FOR ALL
|
|
COMPANY NOMINEES
|
|
OTHER COMPANY NOMINEES
|
|
|
☐
|
☐
|
☐
|
|
|
|
________________
|
|
|
|
________________
|
|
|
|
________________
|
|
|
|
________________
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Mr Klarquist intends to use this proxy to vote "WITHHOLD" on Karen E.
Dyson, Jill R. Goodman, Melina E. Higgins and Robert P. Restrepo Jr. The
names, backgrounds and qualifications of the candidates who have been
nominated by the Company, and other information about them, can be found in
the Company's proxy statement.
INSTRUCTIONS: If you do not wish for your shares to be voted "WITHHOLD"
on a particular nominee, mark the "WITHHOLD ON KAREN E. DYSON, JILL R.
GOODMAN, MELINA E. HIGGINS AND ROBERT P. RESTREPO JR. (EXCEPT AS
WRITTEN BELOW); AND FOR ALL OTHER COMPANY NOMINEES" box and write the
name(s) of the Compensation Committee Directors you do support on the
line(s) above. Your shares of common stock will be voted withhold on
the remaining Compensation Committee Directors.
2. The Company's advisory vote on the compensation of the Company's named
executive officers.
☐ FOR ☐ AGAINST ☐ ABSTAIN
3. The Company's proposal to ratify the selection of KPMG as the Company's
independent auditor for the fiscal year ending December 31, 2022.
☐ FOR ☐ AGAINST ☐ ABSTAIN
DATED: ____________________________, 2022
____________________________________
(Signature)
____________________________________
(Signature, if held jointly)
____________________________________
(Title)
WHEN SHARES ARE HELD JOINTLY, JOINT OWNERS SHOULD EACH SIGN. EXECUTORS,
ADMINISTRATORS, TRUSTEES, ETC., SHOULD INDICATE THE CAPACITY IN WHICH
SIGNING. PLEASE SIGN EXACTLY AS NAME APPEARS ON THIS PROXY.
This regulatory filing also includes additional resources:
gnwpreliminaryproxy472022.pdf
Genworth Financial (NYSE:GNW)
Historical Stock Chart
From Apr 2024 to May 2024
Genworth Financial (NYSE:GNW)
Historical Stock Chart
From May 2023 to May 2024